Literature DB >> 6288620

Viral antibodies in multiple sclerosis.

P Ferrante, D Caputo, S Barbesti, M Fasan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6288620      PMCID: PMC7088060          DOI: 10.1007/bf02043942

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


× No keyword cloud information.
  16 in total

1.  Multiple sclerosis: two or more viruses may be involved.

Authors:  T H Maugh
Journal:  Science       Date:  1977-02-25       Impact factor: 47.728

2.  Current trends in multiple sclerosis research.

Authors:  B H Waksman
Journal:  Immunol Today       Date:  1981-05

3.  Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus.

Authors:  V ter Meulen; H Koprowski; Y Iwasaki; Y M Käckell; D Müller
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

4.  Slow virus E malattie croniche del sistema nervoso centrale.

Authors:  F Bergamini
Journal:  Boll Ist Sieroter Milan       Date:  1978-01-31

Review 5.  Diagnosis and classification of multiple sclerosis.

Authors:  W I McDonald; A M Halliday
Journal:  Br Med Bull       Date:  1977-01       Impact factor: 4.291

6.  Viral antibodies in multiple sclerosis.

Authors:  E Norrby
Journal:  Prog Med Virol       Date:  1978

7.  Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients.

Authors:  J S Burks; B L DeVald; L D Jankovsky; J C Gerdes
Journal:  Science       Date:  1980-08-22       Impact factor: 47.728

8.  Investigation on the role of viral antibodies in the pathogenesis of multiple sclerosis.

Authors:  T V Matveeva; E R Pille; I N Diakonova; A P Andreeva
Journal:  Acta Virol       Date:  1980-12       Impact factor: 1.162

9.  Histocompatibility types and viral antibodies.

Authors:  J R Lehrich; B G Arnason
Journal:  Arch Neurol       Date:  1976-06

10.  Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients.

Authors:  R I Carp; P C Licursi; P A Merz; G S Merz
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.